SERVICES

Zeumed designs, stress-tests, and supports the implementation of payer pricing, reimbursement, and funding frameworks for medicines and health technologies. The focus is on how policy choices play out in practice - for access, affordability, market behaviour, and supply stability, under real fiscal and political constraints.

​

This work sits at the intersection of policy design, economic analysis, and negotiation, and is grounded in an understanding of how pricing and reimbursement decisions interact across products, markets, and time.

​

In practice, this includes:

​

• Design and reform of payer pricing and reimbursement frameworks
  Developing and reviewing pricing and reimbursement rules that balance access and affordability while maintaining predictable expenditure and functional markets — across originators, generics, and biosimilars.

​

• Innovative contracting and funding approaches
  Designing and assessing alternative contracting and payment arrangements where standard approaches are not fit for purpose, including staged payments, outcomes-linked components, expenditure caps, and hybrid models appropriate to the technology and payer context.

​

• Negotiation strategy and preparation
  Supporting payer and government negotiations with manufacturers and suppliers, including preparation of economic and policy positions, anticipation of counter-arguments, and assessment of fiscal and market implications of different negotiation outcomes.

​

• Managing international price linkages and policy spillovers
  Analysing how domestic pricing and reimbursement decisions interact with international reference pricing, MFN-type policies, and cross-market spillovers, including implications for launch sequencing, affordability, and long-term access.

​

• Supply stability and market functioning
  Assessing how pricing, reimbursement, and contracting choices affect incentives for market entry, generic competition, and supply resilience, particularly in settings exposed to shortages or concentration risk.

​

The emphasis throughout is on frameworks that hold over time — through innovation cycles, patent expiry, negotiation rounds, and shifts in global pricing policy.